NUVB
Income statement / Annual
Last year (2025), Nuvation Bio Inc's total revenue was $62.90 M,
an increase of 698.96% from the previous year.
In 2025, Nuvation Bio Inc's net income was -$204.63 M.
See Nuvation Bio Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$62.90 M |
$7.87 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$8.44 M
|
$7.08 M
|
$0.00
|
$0.00
|
$0.00
|
$103.00 K
|
$0.00
|
$0.00
|
| Gross Profit |
$54.46 M
|
$795.00 K
|
$0.00
|
$0.00
|
$0.00
|
-$103.00 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.87
|
0.1
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$115.11 M
|
$524.19 M
|
$71.29 M
|
$87.82 M
|
$69.04 M
|
$32.60 M
|
$25.11 M
|
$482.67 K
|
| General & Administrative Expenses |
$0.00
|
$66.73 M
|
$28.53 M
|
$31.92 M
|
$24.28 M
|
$0.00
|
$6.59 M
|
$509.33 K
|
| Selling & Marketing Expenses |
$0.00
|
$2.50 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$400.00 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$151.56 M
|
$69.23 M
|
$28.53 M
|
$31.92 M
|
$24.28 M
|
$10.85 M
|
$6.99 M
|
$509.33 K
|
| Other Expenses |
$856.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$1.00
|
$0.00
|
| Operating Expenses |
$267.52 M
|
$593.42 M
|
$99.82 M
|
$119.73 M
|
$93.32 M
|
$43.45 M
|
$32.10 M
|
$992.00 K
|
| Cost And Expenses |
$275.97 M
|
$600.50 M
|
$99.82 M
|
$119.73 M
|
$93.32 M
|
$43.55 M
|
$32.10 M
|
$992.00 K
|
| Interest Income |
$21.43 M
|
$27.06 M
|
$24.61 M
|
$7.45 M
|
$2.96 M
|
$1.95 M
|
$1.37 K
|
$0.00
|
| Interest Expense |
$13.68 M
|
$341.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.74 M
|
$683.00 K
|
$222.00 K
|
$199.00 K
|
$184.00 K
|
$103.00 K
|
$13.00 K
|
$992.00 K
|
| EBITDA |
-$189.21 M |
-$566.92 M |
-$75.58 M |
-$104.00 M |
-$86.66 M |
-$41.56 M |
-$32.09 M |
$0.00 |
| EBITDA Ratio |
-3.01
|
-72.01
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-3.39
|
-75.27
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$8.44 M
|
$24.69 M
|
$24.02 M
|
$15.54 M
|
$6.47 M
|
$1.89 M
|
-$1.45 M
|
$0.00
|
| Income Before Tax |
-$204.63 M
|
-$567.94 M
|
-$75.80 M
|
-$104.20 M
|
-$86.85 M
|
-$41.66 M
|
-$33.55 M
|
-$992.00 K
|
| Income Before Tax Ratio |
-3.25
|
-72.14
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$204.63 M
|
-$567.94 M
|
-$75.80 M
|
-$104.20 M
|
-$86.85 M
|
-$41.66 M
|
-$33.55 M
|
-$992.00 K
|
| Net Income Ratio |
-3.25
|
-72.14
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.6 |
-2.11 |
-0.35 |
-0.48 |
-0.44 |
-0.19 |
-0.16 |
-0.0054 |
| EPS Diluted |
-0.6 |
-2.11 |
-0.35 |
-0.48 |
-0.44 |
-0.19 |
-0.16 |
-0.0054 |
| Weighted Average Shares Out |
$341.54 M
|
$268.77 M
|
$218.88 M
|
$216.72 M
|
$197.89 M
|
$217.65 M
|
$206.67 M
|
$183.74 M
|
| Weighted Average Shares Out Diluted |
$341.54 M
|
$268.77 M
|
$218.88 M
|
$216.72 M
|
$197.89 M
|
$217.65 M
|
$206.67 M
|
$183.74 M
|
| Link |
|
|
|
|
|
|
|
|
